TreeWAS – Variant ID: rs1998359

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S00.0 Superficial injury of scalp	0.044	0.956	0.000
S00.9 Superficial injury of head, part unspecified	0.043	0.957	0.000
S00 Superficial injury of head	0.039	0.961	0.000
S00.7 Multiple superficial injuries of head	0.035	0.965	0.000
S00.4 Superficial injury of ear	0.030	0.970	0.000
T42.4 Benzodiazepines	0.000	0.971	0.029
S00.8 Superficial injury of other parts of head	0.027	0.973	0.000
S00.3 Superficial injury of nose	0.024	0.976	0.000
S00.1 Contusion of eyelid and periocular area	0.022	0.978	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.022	0.978	0.000
S00.5 Superficial injury of lip and oral cavity	0.020	0.979	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.987	0.012
L53.9 Erythematous condition, unspecified	0.012	0.988	0.000
T42.0 Hydantoin derivatives	0.000	0.989	0.011
T42.1 Iminostilbenes	0.000	0.990	0.010
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.991	0.009
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.991	0.009
T42.3 Barbiturates	0.000	0.991	0.009
T42.2 Succinimides and oxazolidinediones	0.000	0.991	0.009
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.991	0.009
U80.1 Methicillin resistant agent	0.000	0.991	0.009
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.993	0.007
L53 Other erythematous conditions	0.007	0.993	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.000	0.993	0.007
S32.50 Fracture of pubis (closed)	0.007	0.993	0.000
H43.1 Vitreous haemorrhage	0.000	0.993	0.007
L53.8 Other specified erythematous conditions	0.006	0.994	0.000
C15.5 Lower third of oesophagus	0.006	0.994	0.000
R23 Other skin changes	0.000	0.995	0.005
L53.3 Other chronic figurate erythema	0.005	0.995	0.000
L53.2 Erythema marginatum	0.005	0.995	0.000
L53.1 Erythema annulare centrifugum	0.005	0.995	0.000
R23.8 Other and unspecified skin changes	0.000	0.995	0.005
R23.4 Changes in skin texture	0.000	0.995	0.005
U80 Agent resistant to penicillin and related antibiotics	0.000	0.995	0.005
L53.0 Toxic erythema	0.005	0.995	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.005	0.995	0.000
R23.1 Pallor	0.000	0.995	0.005
R23.2 Flushing	0.000	0.995	0.005
H57.1 Ocular pain	0.000	0.995	0.005
H57.0 Anomalies of pupillary function	0.000	0.995	0.005
R76.8 Other specified abnormal immunological findings in serum	0.005	0.995	0.000
M41.9 Scoliosis, unspecified	0.000	0.995	0.005
R23.3 Spontaneous ecchymoses	0.000	0.995	0.005
S32.5 Fracture of pubis	0.005	0.995	0.000
U80.0 Penicillin resistant agent	0.000	0.995	0.005
R59.1 Generalised enlarged lymph nodes	0.004	0.996	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.996	0.004
R23.0 Cyanosis	0.000	0.996	0.004
O69.1 Labour and delivery complicated by cord around neck, with compression	0.000	0.996	0.004
S42.40 Fracture of lower end of humerus (closed)	0.000	0.996	0.004
C45.9 Mesothelioma, unspecified	0.004	0.996	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.996	0.004
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.996	0.004
C45.7 Mesothelioma of other sites	0.004	0.996	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.996	0.004
H57 Other disorders of eye and adnexa	0.000	0.996	0.004
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.996	0.004
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.996	0.004
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.996	0.004
M41.92 Scoliosis, unspecified (Cervical region)	0.000	0.996	0.004
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.996	0.004
S42.20 Fracture of upper end of humerus (closed)	0.000	0.996	0.004
C45 Mesothelioma	0.004	0.996	0.000
S32.51 Fracture of pubis (open)	0.003	0.996	0.000
G82.2 Paraplegia, unspecified	0.000	0.996	0.004
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.997	0.003
C54.1 Endometrium	0.003	0.997	0.000
O80.0 Spontaneous vertex delivery	0.003	0.997	0.000
S42.4 Fracture of lower end of humerus	0.000	0.997	0.003
M84.03 Malunion of fracture (Forearm)	0.000	0.997	0.003
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.997	0.003
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.997	0.003
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.002	0.997	0.001
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.997	0.003
H65.3 Chronic mucoid otitis media	0.003	0.997	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.000	0.997	0.003
S42.2 Fracture of upper end of humerus	0.000	0.997	0.003
C15 Malignant neoplasm of oesophagus	0.003	0.997	0.000
J43.9 Emphysema, unspecified	0.000	0.997	0.003
R57.2 Septic shock	0.000	0.997	0.003
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.997	0.003
Q25 Congenital malformations of great arteries	0.003	0.997	0.000
H65.2 Chronic serous otitis media	0.003	0.997	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.997	0.003
Q24 Other congenital malformations of heart	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
W06.0 Home	0.003	0.997	0.000
C45.0 Mesothelioma of pleura	0.003	0.997	0.000
R16.1 Splenomegaly, not elsewhere classified	0.000	0.997	0.003
U51 Admission status on psychiatric patients	0.000	0.997	0.003
C45.2 Mesothelioma of pericardium	0.003	0.997	0.000
C45.1 Mesothelioma of peritoneum	0.003	0.997	0.000
T36.0 Penicillins	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
Q21.0 Ventricular septal defect	0.003	0.997	0.000
Q25.6 Stenosis of pulmonary artery	0.003	0.997	0.000
Q25.0 Patent ductus arteriosus	0.003	0.997	0.000
Q21 Congenital malformations of cardiac septa	0.003	0.997	0.000
S42 Fracture of shoulder and upper arm	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
H65 Nonsuppurative otitis media	0.003	0.997	0.000
Q24.8 Other specified congenital malformations of heart	0.003	0.997	0.000
C15.3 Upper third of oesophagus	0.003	0.997	0.000
Q24.0 Dextrocardia	0.003	0.997	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.003	0.997	0.000
N30.1 Interstitial cystitis (chronic)	0.003	0.997	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.003	0.997	0.000
S32 Fracture of lumbar spine and pelvis	0.003	0.997	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.997	0.003
C15.9 Oesophagus, unspecified	0.003	0.997	0.000
C15.1 Thoracic part of oesophagus	0.003	0.997	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.003	0.997	0.000
G82 Paraplegia and tetraplegia	0.000	0.997	0.003
D06.9 Cervix, unspecified	0.003	0.997	0.000
M41 Scoliosis	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
S42.0 Fracture of clavicle	0.000	0.997	0.003
H59.0 Vitreous syndrome following cataract surgery	0.002	0.997	0.001
H65.1 Other acute nonsuppurative otitis media	0.002	0.997	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.003	0.997	0.000
U50 Level of care administered to neonates	0.000	0.997	0.002
U07 Emergency use of U07	0.000	0.997	0.002
U06 Emergency use of U06	0.000	0.997	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.002
U52 First in a series of a regular day/night admissions	0.000	0.997	0.002
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.000	0.997	0.002
H58.1 Visual disturbances in diseases classified elsewhere	0.000	0.997	0.002
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.000	0.997	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
S42.21 Fracture of upper end of humerus (open)	0.000	0.997	0.002
C15.8 Overlapping lesion of oesophagus	0.002	0.997	0.000
C15.2 Abdominal part of oesophagus	0.002	0.997	0.000
C15.0 Cervical part of oesophagus	0.002	0.997	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.003	0.997	0.000
G82.4 Spastic tetraplegia	0.000	0.997	0.002
H65.4 Other chronic nonsuppurative otitis media	0.002	0.997	0.000
S32.0 Fracture of lumbar vertebra	0.002	0.997	0.000
S42.3 Fracture of shaft of humerus	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
R76 Other abnormal immunological findings in serum	0.002	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
S99.9 Unspecified injury of ankle and foot	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
H55-H59 Other disorders of eye and adnexa	0.000	0.998	0.002
Q25.1 Coarctation of aorta	0.002	0.998	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.002	0.998	0.001
Q25.9 Congenital malformation of great arteries, unspecified	0.002	0.998	0.000
Q25.8 Other congenital malformations of great arteries	0.002	0.998	0.000
Q25.5 Atresia of pulmonary artery	0.002	0.998	0.000
Q25.4 Other congenital malformations of aorta	0.002	0.998	0.000
Q25.3 Stenosis of aorta	0.002	0.998	0.000
Q25.2 Atresia of aorta	0.002	0.998	0.000
O02.0 Blighted ovum and nonhydatidiform mole	0.002	0.998	0.000
Q24.6 Congenital heart block	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.002	0.998	0.000
Q24.2 Cor triatriatum	0.002	0.998	0.000
Q24.1 Levocardia	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
Q24.5 Malformation of coronary vessels	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.002	0.998	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
L50-L54 Urticaria and erythema	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.002	0.998	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
S32.1 Fracture of sacrum	0.002	0.998	0.000
S42.41 Fracture of lower end of humerus (open)	0.000	0.998	0.002
Q21.9 Congenital malformation of cardiac septum, unspecified	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
Q21.8 Other congenital malformations of cardiac septa	0.002	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.002	0.998	0.000
Q21.2 Atrioventricular septal defect	0.002	0.998	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.002	0.998	0.000
S42.8 Fracture of other parts of shoulder and upper arm	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.002	0.998	0.000
S42.1 Fracture of scapula	0.000	0.998	0.002
G82.1 Spastic paraplegia	0.000	0.998	0.002
C15.4 Middle third of oesophagus	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.998	0.002
Q21.3 Tetralogy of Fallot	0.002	0.998	0.000
S42.7 Multiple fractures of clavicle, scapula and humerus	0.000	0.998	0.002
N64.9 Disorder of breast, unspecified	0.002	0.998	0.000
S32.2 Fracture of coccyx	0.002	0.998	0.000
M41.8 Other forms of scoliosis	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
G82.3 Flaccid tetraplegia	0.000	0.998	0.002
G82.0 Flaccid paraplegia	0.000	0.998	0.002
R76.0 Raised antibody titer	0.002	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
E10.4 With neurological complications	0.000	0.998	0.002
M41.5 Other secondary scoliosis	0.000	0.998	0.002
M41.4 Neuromuscular scoliosis	0.000	0.998	0.002
M41.3 Thoracogenic scoliosis	0.000	0.998	0.002
M41.2 Other idiopathic scoliosis	0.000	0.998	0.002
M41.1 Juvenile idiopathic scoliosis	0.000	0.998	0.002
M41.0 Infantile idiopathic scoliosis	0.000	0.998	0.002
S32.3 Fracture of ilium	0.002	0.998	0.000
Q22.5 Ebstein's anomaly	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
S32.10 Fracture of sacrum (closed)	0.002	0.998	0.000
S42.01 Fracture of clavicle (open)	0.000	0.998	0.002
R22.1 Localised swelling, mass and lump, neck	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.002
U06.9 Emergency use of U06.9	0.000	0.998	0.002
U06.8 Emergency use of U06.8	0.000	0.998	0.002
U06.7 Emergency use of U06.7	0.000	0.998	0.002
U06.6 Emergency use of U06.6	0.000	0.998	0.002
U06.5 Emergency use of U06.5	0.000	0.998	0.002
U06.4 Emergency use of U06.4	0.000	0.998	0.002
U06.3 Emergency use of U06.3	0.000	0.998	0.002
U06.2 Emergency use of U06.2	0.000	0.998	0.002
U06.1 Emergency use of U06.1	0.000	0.998	0.002
U06.0 Emergency use of U06.0	0.000	0.998	0.002
U07.9 Emergency use of U07.9	0.000	0.998	0.002
U07.8 Emergency use of U07.8	0.000	0.998	0.002
U07.7 Emergency use of U07.7	0.000	0.998	0.002
U07.6 Emergency use of U07.6	0.000	0.998	0.002
U07.5 Emergency use of U07.5	0.000	0.998	0.002
U07.4 Emergency use of U07.4	0.000	0.998	0.002
U07.3 Emergency use of U07.3	0.000	0.998	0.002
U07.2 Emergency use of U07.2	0.000	0.998	0.002
U07.1 Emergency use of U07.1	0.000	0.998	0.002
U07.0 Emergency use of U07.0	0.000	0.998	0.002
U50.9 Inquest Adjourned Death	0.000	0.998	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.002
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
S19.9 Unspecified injury of neck	0.000	0.998	0.002
L51 Erythema multiforme	0.002	0.998	0.000
S32.01 Fracture of lumbar vertebra (open)	0.002	0.998	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.998	0.002
H57.8 Other specified disorders of eye and adnexa	0.000	0.998	0.002
K35.0 Acute appendicitis with generalised peritonitis	0.002	0.998	0.000
L91.0 Keloid scar	0.002	0.998	0.000
O02.1 Missed abortion	0.002	0.998	0.000
S42.9 Fracture of shoulder girdle, part unspecified	0.000	0.998	0.002
S42.31 Fracture of shaft of humerus (open)	0.000	0.998	0.002
L51.1 Bullous erythema multiforme	0.002	0.998	0.000
R76.9 Abnormal immunological finding in serum, unspecified	0.002	0.998	0.000
R76.2 False-positive serological test for syphilis	0.002	0.998	0.000
R76.1 Abnormal reaction to tuberculin test	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
G82.5 Tetraplegia, unspecified	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
H65.0 Acute serous otitis media	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
L54 Erythema in diseases classified elsewhere	0.002	0.998	0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.002	0.998	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.002	0.998	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.002	0.998	0.000
Q22.6 Hypoplastic right heart syndrome	0.002	0.998	0.000
Q22.4 Congenital tricuspid stenosis	0.002	0.998	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.002	0.998	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.002	0.998	0.000
Q22.1 Congenital pulmonary valve stenosis	0.002	0.998	0.000
Q22.0 Pulmonary valve atresia	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.002
S32.11 Fracture of sacrum (open)	0.002	0.998	0.000
T47.4 Other laxatives	0.000	0.998	0.002
R52.1 Chronic intractable pain	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.002	0.998	0.000
S42.81 Fracture of other parts of shoulder and upper arm (open)	0.000	0.998	0.002
S42.80 Fracture of other parts of shoulder and upper arm (closed)	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
V19.8 Pedal cyclist [any] injured in other specified transport accidents	0.002	0.998	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.998	0.002
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.002	0.998	0.000
S42.11 Fracture of scapula (open)	0.000	0.998	0.002
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
M41.86 Other forms of scoliosis (Lumbar region)	0.000	0.998	0.002
G80.9 Infantile cerebral palsy, unspecified	0.000	0.998	0.002
H54.7 Unspecified visual loss	0.000	0.998	0.002
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.002	0.998	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q20.6 Isomerism of atrial appendages	0.002	0.998	0.000
Q20.5 Discordant atrioventricular connexion	0.002	0.998	0.000
Q20.4 Double inlet ventricle	0.002	0.998	0.000
Q20.3 Discordant ventriculoarterial connexion	0.002	0.998	0.000
Q20.2 Double outlet left ventricle	0.002	0.998	0.000
Q20.1 Double outlet right ventricle	0.002	0.998	0.000
Q20.0 Common arterial trunk	0.002	0.998	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.002	0.998	0.000
Q26.8 Other congenital malformations of great veins	0.002	0.998	0.000
Q26.6 Portal vein-hepatic artery fistula	0.002	0.998	0.000
Q26.5 Anomalous portal venous connexion	0.002	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.002	0.998	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.1 Persistent left superior vena cava	0.002	0.998	0.000
Q26.0 Congenital stenosis of vena cava	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
C54 Malignant neoplasm of corpus uteri	0.002	0.998	0.000
S42.71 Multiple fractures of clavicle, scapula and humerus (open)	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
M41.89 Other forms of scoliosis (Site unspecified)	0.000	0.998	0.002
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.87 Other forms of scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.85 Other forms of scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.84 Other forms of scoliosis (Thoracic region)	0.000	0.998	0.002
M41.83 Other forms of scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.82 Other forms of scoliosis (Cervical region)	0.000	0.998	0.002
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.80 Other forms of scoliosis (Multiple sites in spine)	0.000	0.998	0.002
S32.21 Fracture of coccyx (open)	0.002	0.998	0.000
S32.20 Fracture of coccyx (closed)	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
H53.4 Visual field defects	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
S32.31 Fracture of ilium (open)	0.002	0.998	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
X41.9 Unspecified place	0.000	0.998	0.002
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.29 Other idiopathic scoliosis (Site unspecified)	0.000	0.998	0.002
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.26 Other idiopathic scoliosis (Lumbar region)	0.000	0.998	0.002
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.24 Other idiopathic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.22 Other idiopathic scoliosis (Cervical region)	0.000	0.998	0.002
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.39 Thoracogenic scoliosis-Site unspe	0.000	0.998	0.002
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.000	0.998	0.002
M41.37 Thoracogenic scoliosis-Lumbosacral	0.000	0.998	0.002
M41.36 Thoracogenic scoliosis-Lumbar	0.000	0.998	0.002
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.34 Thoracogenic scoliosis (Thoracic region)	0.000	0.998	0.002
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.32 Thoracogenic scoliosis-Cervical	0.000	0.998	0.002
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.000	0.998	0.002
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.49 Neuromuscular scoliosis (Site unspecified)	0.000	0.998	0.002
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.46 Neuromuscular scoliosis (Lumbar region)	0.000	0.998	0.002
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.44 Neuromuscular scoliosis (Thoracic region)	0.000	0.998	0.002
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.42 Neuromuscular scoliosis (Cervical region)	0.000	0.998	0.002
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.000	0.998	0.002
M41.59 Other secondary scoliosis (Site unspecified)	0.000	0.998	0.002
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M41.57 Other secondary scoliosis (Lumbosacral region)	0.000	0.998	0.002
M41.56 Other secondary scoliosis (Lumbar region)	0.000	0.998	0.002
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.000	0.998	0.002
M41.54 Other secondary scoliosis (Thoracic region)	0.000	0.998	0.002
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.000	0.998	0.002
M41.52 Other secondary scoliosis (Cervical region)	0.000	0.998	0.002
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.000	0.998	0.002
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.000	0.998	0.002
Q27.4 Congenital phlebectasia	0.002	0.998	0.000
Q27.3 Peripheral arteriovenous malformation	0.002	0.998	0.000
Q27.2 Other congenital malformations of renal artery	0.002	0.998	0.000
Q27.1 Congenital renal artery stenosis	0.002	0.998	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.002	0.998	0.000
O02 Other abnormal products of conception	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.998	0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.000	0.998	0.002
L51.8 Other erythema multiforme	0.002	0.998	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.002	0.998	0.000
L51.0 Nonbullous erythema multiforme	0.002	0.998	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
V49 Car occupant injured in other and unspecified transport accidents	0.000	0.998	0.002
S42.91 Fracture of shoulder girdle, part unspecified (open)	0.000	0.998	0.002
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.002	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.002	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.002	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.002	0.998	0.000
Q23.2 Congenital mitral stenosis	0.002	0.998	0.000
U81.0 Vancomycin resistant agent	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations